ticagrelor - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
BRILINTA ODT ticagrelor 90 mg orodispersible tablet blister pack
AUST R: 303878
Active ingredients:
ticagrelor

Dosage form:
Tablet, dispersible

Sponsor:
AstraZeneca Pty Ltd

Phone:
1800805342

Deletion from market:
30 Sep 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Other dosage forms and brands are available.